The University of Chicago Header Logo

Connection

Thomas N. Krausz to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications Thomas N. Krausz has written about Biomarkers, Tumor.
Thomas N. Krausz
Connection Strength
2.861
Biomarkers, Tumor
  1. Immunohistochemical evaluation of nuclear 5-hydroxymethylcytosine (5-hmC) accurately distinguishes malignant pleural mesothelioma from benign mesothelial proliferations. Mod Pathol. 2019 03; 32(3):376-386.
    View in: PubMed
    Score: 0.373
  2. BAP1 immunohistochemistry has limited prognostic utility as a complement of CDKN2A (p16) fluorescence in situ hybridization in malignant pleural mesothelioma. Hum Pathol. 2017 02; 60:86-94.
    View in: PubMed
    Score: 0.325
  3. A Pilot Study of Galectin-3, HBME-1, and p27 Triple Immunostaining Pattern for Diagnosis of Indeterminate Thyroid Nodules in Cytology With Correlation to Histology. Appl Immunohistochem Mol Morphol. 2015 Aug; 23(7):481-90.
    View in: PubMed
    Score: 0.299
  4. BAP1 facilitates diagnostic objectivity, classification, and prognostication in malignant pleural mesothelioma. Hum Pathol. 2015 Nov; 46(11):1670-8.
    View in: PubMed
    Score: 0.298
  5. Salivary gland-type tumors of the breast: a spectrum of benign and malignant tumors including "triple negative carcinomas" of low malignant potential. Semin Diagn Pathol. 2010 Feb; 27(1):77-90.
    View in: PubMed
    Score: 0.204
  6. Improved Survival Associated with Local Tumor Response Following Multisite Radiotherapy and Pembrolizumab: Secondary Analysis of a Phase I Trial. Clin Cancer Res. 2020 12 15; 26(24):6437-6444.
    View in: PubMed
    Score: 0.107
  7. Female adnexal tumors of probable Wolffian origin: morphological, immunohistochemical, and molecular analysis of 15 cases. Mod Pathol. 2020 04; 33(4):734-747.
    View in: PubMed
    Score: 0.100
  8. Loss of microfibril-associated protein 5 (MFAP5) expression in colon cancer stroma. Virchows Arch. 2020 Mar; 476(3):383-390.
    View in: PubMed
    Score: 0.099
  9. MTAP immunohistochemistry is an accurate and reproducible surrogate for CDKN2A fluorescence in situ hybridization in diagnosis of malignant pleural mesothelioma. Mod Pathol. 2020 02; 33(2):245-254.
    View in: PubMed
    Score: 0.098
  10. Ubiquitin Immunostaining in Thyroid Neoplasms Marks True Intranuclear Cytoplasmic Pseudoinclusions and May Help Differentiate Papillary Carcinoma from NIFTP. Head Neck Pathol. 2018 Dec; 12(4):522-528.
    View in: PubMed
    Score: 0.089
  11. PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma. Am J Surg Pathol. 2017 Dec; 41(12):1675-1682.
    View in: PubMed
    Score: 0.088
  12. Melanotic PEComa of the Sinonasal Mucosa With NONO-TFE3 Fusion: An Elusive Mimic of Sinonasal Melanoma. Am J Surg Pathol. 2017 May; 41(5):717-722.
    View in: PubMed
    Score: 0.084
  13. Primary epithelioid sarcoma of the kidney and adrenal gland: report of 2 cases with immunohistochemical and molecular cytogenetic studies. Hum Pathol. 2017 03; 61:158-163.
    View in: PubMed
    Score: 0.081
  14. Frequent FOS Gene Rearrangements in Epithelioid Hemangioma: A Molecular Study of 58 Cases With Morphologic Reappraisal. Am J Surg Pathol. 2015 Oct; 39(10):1313-21.
    View in: PubMed
    Score: 0.076
  15. How useful is GLUT-1 in differentiating mesothelial hyperplasia and fibrosing pleuritis from epithelioid and sarcomatoid mesotheliomas? An international collaborative study. Lung Cancer. 2014 Mar; 83(3):324-8.
    View in: PubMed
    Score: 0.067
  16. Arginase-1: a new immunohistochemical marker of hepatocytes and hepatocellular neoplasms. Am J Surg Pathol. 2010 Aug; 34(8):1147-54.
    View in: PubMed
    Score: 0.053
  17. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Mod Pathol. 2008 Jun; 21(6):647-52.
    View in: PubMed
    Score: 0.045
  18. Pneumocytic adenomyoepithelioma: a distinctive lung tumor with epithelial, myoepithelial, and pneumocytic differentiation. Am J Surg Pathol. 2007 Apr; 31(4):562-8.
    View in: PubMed
    Score: 0.042
  19. Expression of vitamin D3 receptor in kidney tumors. Hum Pathol. 2006 Oct; 37(10):1268-78.
    View in: PubMed
    Score: 0.040
  20. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker. Histopathology. 2004 Sep; 45(3):218-25.
    View in: PubMed
    Score: 0.035
  21. Expression of alpha-methylacyl-CoA racemase in papillary renal cell carcinoma. Am J Surg Pathol. 2004 Jan; 28(1):69-76.
    View in: PubMed
    Score: 0.033
  22. Mesothelioma in situ of the peritoneum: report of three cases and review of the literature. Histopathology. 2024 Feb; 84(3):492-506.
    View in: PubMed
    Score: 0.033
  23. Abnormal immunoreactivity of the E-cadherin/catenin (alpha-, beta-, and gamma-) complex in premalignant and malignant non-melanocytic skin tumours. J Pathol. 2002 Feb; 196(2):154-62.
    View in: PubMed
    Score: 0.029
  24. Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases. Mod Pathol. 2021 02; 34(2):380-395.
    View in: PubMed
    Score: 0.027
  25. Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays. Hum Pathol. 2019 05; 87:11-17.
    View in: PubMed
    Score: 0.024
  26. Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2017 Update of the Consensus Statement From the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2018 Jan; 142(1):89-108.
    View in: PubMed
    Score: 0.021
  27. Pseudoangiosarcomatous urothelial carcinoma of the urinary bladder. Am J Surg Pathol. 2014 Sep; 38(9):1251-9.
    View in: PubMed
    Score: 0.018
  28. Carbonic anhydrase IX (CAIX) does not differentiate between benign and malignant mesothelium. Am J Clin Pathol. 2014 Jul; 142(1):82-7.
    View in: PubMed
    Score: 0.017
  29. Expression profiling of 519 kinase genes in matched malignant peripheral nerve sheath tumor/plexiform neurofibroma samples is discriminatory and identifies mitotic regulators BUB1B, PBK and NEK2 as overexpressed with transformation. Mod Pathol. 2013 Jul; 26(7):930-43.
    View in: PubMed
    Score: 0.016
  30. Guidelines for pathologic diagnosis of malignant mesothelioma: a consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2009 Aug; 133(8):1317-31.
    View in: PubMed
    Score: 0.012
  31. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol Syst Biol. 2008; 4:188.
    View in: PubMed
    Score: 0.011
  32. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997 Feb; 21(2):130-46.
    View in: PubMed
    Score: 0.005
  33. Combined choriocarcinoma and yolk sac tumor arising in Barrett's esophagus. Cancer. 1994 Feb 01; 73(3):514-7.
    View in: PubMed
    Score: 0.004
  34. p53 immunostaining as a marker of malignant disease in diagnostic cytopathology. Lancet. 1991 Aug 24; 338(8765):513.
    View in: PubMed
    Score: 0.004
  35. Intravesical administration of radiolabeled antitumor monoclonal antibody in bladder carcinoma. Cancer Res. 1991 Jan 15; 51(2):724-8.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.